key: cord-1020072-2j0b6du3
authors: Cramer, Holger; Hannan, Nicole; Schloss, Janet; Leach, Matthew; Lloyd, Iva; Steel, Amie
title: Multivitamins for acute respiratory tract infections: a rapid review
date: 2020-07-30
journal: Adv Integr Med
DOI: 10.1016/j.aimed.2020.07.010
sha: 2019c5c8c8d05c3f9a98b14c4407edac5f19366b
doc_id: 1020072
cord_uid: 2j0b6du3

nan

Seven human clinical trials with some risk of bias suggest that multivitamins may be a safe and effective intervention to relieve some symptoms of respiratory tract infections, increase micronutrient status and immune function; however, further research is needed. There is currently insufficient evidence to recommend multivitamins as a therapy for the treatment or prevention of COVID-19.

The overall quality of research examining the effect of prophylactic multivitamin supplementation on the effects of the acute respiratory tract infections (ARTI) is weak. Most of the available research included adults aged 50 years or over recruited through either the community or institutional settings (i.e. hospital facility, residential care facility). The multivitamin supplements used contained at least five vitamins and minerals and were administered between three months and two years (median: 15 months).

Based on the available evidence, multivitamin supplementation does not appear to reduce the incidence of ARTI or mortality (both ARTI-related and all-cause). The effect of multivitamins taken before infection on the duration of ARTI is unclear due to conflicting results across studies.

Multivitamins may, however, reduce the symptoms associated with ARTI such as headache, conjunctivitis, and activity restriction but not the overall symptom scores. No differences in health service visits, inclusive of primary and tertiary care, has been identified for individuals taking a multivitamin prior to an ARTI.

Background Inadequate intake of vitamins is common 1 and has a detrimental effect on normal immune function. 2 Multivitamin supplementation at the recommended dietary allowance level thus can improved cellular immune parameters and reduce the risk of infections 3 . Multivitamins are frequently used by the general population, 4 and are also frequently recommended by naturopaths . 5 The aim of this rapid review was to assess the effects of multivitamin supplementation on acute respiratory tract infections (ARTI) and associated complications.

The rapid review protocol was created a prioiri and not changed during the conduct of the review.

What are the effects of multivitamin supplementation on acute respiratory tract infections (ARTI) and associated complications? 

The search strategy for Medline is shown in table 1.

J o u r n a l P r e -p r o o f

Two review authors independently screened titles, abstracts and full-texts. Data were extracted from each paper by one review author, with two authors sharing data extraction across the included papers.

The risk of bias (RoB) of study findings in each included paper was assessed by one review author using the revised Cochrane RoB tool for randomised trials (RoB 2) (https://sites.google.com/site/riskofbiastool/welcome/rob-2-0-tool/current-version-of-rob-2?authuser=0). Two authors undertook this task for the included manuscripts.

The search identified 233 citations, including 36 duplicates. The remaining 198 citations were screened by title and abstract against the inclusion and exclusion criteria, and 180 citations were excluded. The full text of 18 citations were assessed for eligibility and 11 were excluded as they sampled the wrong population (n=3), were not reporting original research (n=2), reported a different outcome (n=2), were retracted (n=2), or used the wrong intervention or study design (n=2). The remaining seven studies were included in this rapid review.

All seven included studies were randomised controlled trials. Six studies were described as doubleblind. [6] [7] [8] [9] [10] [11] . The level of blinding in the remaining study was not defined. 12 Most (n=5) studies were undertaken in the World Health Organisation (WHO) European region; this included two studies in France, 7, 8 one each in the Netherlands 9 , UK, 6 and Germany. 11 The remaining studies were conducted in the WHO South-East Asia Region (i.e. India) 12 and the WHO Region of the Americas (i.e. Canada). 10 The seven included studies comprised a total pool of 3,644 participants. Sample sizes ranged between 36 and 910. All participants were adults aged ≥18 years; six of seven studies recruited adults aged ≥50 years. [6] [7] [8] [11] [12] [13] Participants were recruited from the community in four studies, 6, [11] [12] [13] and through institutional settings (i.e. hospital, residential care facility) in three. 7, 8, 10 Multivitamins were administered daily in oral form in all seven studies, either as tablets (n=3) 6,10,11 or capsules (n=4). [7] [8] [9] 12 All interventions contained a combination of at least five vitamins and minerals. Treatment duration ranged from three months to two years, with a median duration of 15 months. Control groups received either matching placebo (n=4), 7, 8, 10, 11 other vitamin/mineral combination (n=2), 9, 12 sorbitol (n=1) 6 or soybean oil (n=1). 9

In the first Domain (randomisation process), four studies were rated as having low risk of bias, 6, 7, 9, 10 and three were assessed as having some risk of bias. 8, 11, 12 For Domain 2 (treatment assignment), most (n=5) studies were determined to have low risk of bias, 6, 7, [9] [10] [11] with one rated as having some risk of bias, 8 and one identified as having high risk of bias. 12 Under Domain 3 (missing outcome data), all studies were assessed as having low risk of bias, except Jain (2002) , which was rated as having high risk of bias. 12 For Domain 4 (measure of outcomes), all studies were rated as having low risk of bias. In Domain 5 (selective reporting), all trials were identified as having some risk of bias. Overall, one study was rated as having high risk of bias, 12 while the remaining six studies were judged as J o u r n a l P r e -p r o o f having some risk of bias. [6] [7] [8] [9] [10] [11] These judgements should be taken into consideration when interpreting the findings of this review.

The seven included studies reported on ten distinct outcomes, including incidence of ARTI, severity of ARTI, infectious morbidity and symptoms, mortality rate, health service contact rate, quality of life, antibiotic use, micronutrient status, cellular immune response and adverse events (see Table 2 ).

Four studies measured the incidence of ARTI. [9] [10] [11] [12] In all four studies, the difference between groups in the incidence of ARTI was not found to be statistically significant.

Duration of ARTI was examined in four studies. 6, 9, 11, 12 The study findings were inconsistent, with two studies reporting a statistically significant reduction in the duration of respiratory illness/ARTI symptoms, 11, 12 and two studies reporting no difference between groups in the duration of ARTI. 6, 13 One study 13 did report a statistically significantly longer duration of ARTI symptoms among participants receiving multivitamin plus high-dose vitamin E when compared with placebo, but no difference was evident between multivitamin and placebo.

Two studies investigated infectious morbidity and symptoms; this included number of symptoms, 9, 11 presence/duration of fever, 11,13 activity restriction, 13 and total symptom score. 11 Studies reported a significant reduction in headache, conjunctivitis and activity restriction 9 in participants receiving multivitamins compared to placebo, but no difference between groups in total symptom score 11 or number of ARTI/influenza symptoms. 11, 13 There were inconsistencies in the reported effect of multivitamins on the presence/duration of fever.

Mortality rate was measured in two studies, including all-cause mortality rate 7 and infection mortality rate. 7, 8 Neither study found a significant difference between groups in participant mortality rates.

Two studies examined health service contact rate, including number of primary care contacts for infection, 6 number of emergency department presentations, 10 number of hospital admissions, number of days in hospital with infection 6 and number of outpatient visits for infection. 6 Neither study found a difference in health service contact rate (for any service setting) between the intervention and control groups.

One study assessed quality of life, using both the EuroQoL and SF-12. 6 The study found no significant difference between multivitamin and placebo groups in either quality of life measure.

Antibiotic use was examined in three studies; this included the number of antibiotic prescriptions 6,10 and number of antibiotic days. 6,10,12 Study findings were inconsistent, with two studies 6, 10 reporting no difference in the number of antibiotic prescriptions or days of antibiotic use between intervention and control groups, and one study 12 reporting significantly fewer days of antibiotic use among participants receiving a multivitamin relative to a calcium-magnesium supplement.

Micronutrient status (i.e. serum micronutrient measurement) was assessed in one study. 7 A significant increase in vitamin and trace element serum levels was observed in all supplementation groups over the six months of study intervention.

One study examined changes in cellular immune response (i.e. white blood cell count and activity). 11 The study reported a significantly greater increase in total leukocyte, lymphocyte, T-lymphocyte, CD4+ and CD8+ lymphocyte and monocyte count in the intervention group after 14 days of treatment when compared with placebo. No changes were observed in T-lymphocyte activation and phagocytic activity for either groups.

Adverse events were assessed in one study. 6 Fewer adverse events were reported in the intervention group when compared with placebo (28 [6.1%] vs. 37 [8.2%] cases). These events were classed as non-serious, and included symptoms such as headache, insomnia and gout.

Based on the evidence identified in this rapid review, multivitamins may be a safe and effective intervention to relieve some symptoms of ARTI, increase micronutrient status and immune function. Effects on respiratory tract infection duration and antibiotics use are inconsistent; and multivitamins do not seem to reduce health services contact or mortality. At this time, there is insufficient evidence to recommend the use of multivitamins in the treatment or prevention of COVID-19.

This article has not been peer-reviewed; it should not replace individual clinical judgement. The views expressed in this rapid review are the views of the authors and not necessarily from the host institutions. The views are not a substitute for professional medical advice. J o u r n a l P r e -p r o o f 

Hazels Mitmesser S. Inadequacy of Immune Health Nutrients: Intakes in US Adults, the 2005-2016 NHANES

Vitamin effects on the immune system: vitamins A and D take centre stage

A Review of Micronutrients and the Immune System-Working in Harmony to Reduce the Risk of Infection

Trends in Dietary Supplement Use Among US Adults From

Pediatric natural health products recommended by chiropractic and naturopathic doctors in Canada

Effect of multivitamin and multimineral supplements on morbidity from infections in older people (MAVIS trial): Pragmatic, randomised, double blind, placebo controlled trial

Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters

Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized controlled trial. MIN. VIT. AOX. geriatric network

Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: A randomized controlled trial

Effect of multivitamin and mineral supplementation on episodes of infection in nursing home residents: A randomized, placebo-controlled study

Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters

Influence of vitamins and trace-elements on the incidence of respiratory infection in the elderly

Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial

J o u r n a l P r e -p r o o f , ribofl avin1. 5